Patents by Inventor Brent Zanke

Brent Zanke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
    Patent number: 9896728
    Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: February 20, 2018
    Assignee: ArcticRx Ltd.
    Inventors: Brent Zanke, Carl Awh
  • METHOD FOR DETERMINING A THERAPEUTIC APPROACH FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
    Publication number: 20180023141
    Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 25, 2018
    Inventors: Brent Zanke, Carl Awh
  • METHOD FOR DETERMINING A SUPPLEMENT COMPOSITION FOR PREVENTING DEVELOPMENT OF DRY INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
    Publication number: 20170166969
    Abstract: Disclosed is a method for determining a supplement regime for a subject with normal eyes or AREDS category 1 AMD to minimize the development of intermediate dry (AREDS category 3) AMD. The method involves determining the subject's genetic risk profile for the complement factor H gene and ARMS2 gene and administering an antioxidant/carotenoid supplement if the individual has high genetic risk and avoiding the administration of such a supplement, which increases the risk for AMD, in those with low risk disease.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 15, 2017
    Inventors: Rafall Kustra, Brent Zanke
  • METHOD FOR DETERMINING A THERAPEUTIC APPROACH FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
    Publication number: 20140212507
    Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.
    Type: Application
    Filed: July 31, 2013
    Publication date: July 31, 2014
    Applicant: ArcticDx Inc.
    Inventors: Brent Zanke, Carl Awh